An in vitro model maintaining taxon-specific functional activities of the gut microbiome.

["Li L", "Abou-Samra E", "Ning Z", "Zhang X", "Mayne J", "Wang J", "Cheng K", "Walker K", "Stintzi A", "Figeys D"]
Nature communications 2019
Open on PubMed

In vitro gut microbiome models could provide timely and cost-efficient solutions to study microbiome responses to drugs. For this purpose, in vitro models that maintain the functional and compositional profiles of in vivo gut microbiomes would be extremely valuable. Here, we present a 96-deep well plate-based culturing model (MiPro) that maintains the functional and compositional profiles of individual gut microbiomes, as assessed by metaproteomics, while allowing a four-fold increase in viable bacteria counts. Comparison of taxon-specific functions between pre- and post-culture microbiomes shows a Pearson's correlation coefficient r of 0.83 ± 0.03. In addition, we show a high degree of correlation between gut microbiome responses to metformin in the MiPro model and those in mice fed a high-fat diet. We propose MiPro as an in vitro gut microbiome model for scalable investigation of drug-microbiome interactions such as during high-throughput drug screening.

4 Figures Extracted
Fig. 1
Fig. 1 PMC
Establishment and general performance of the MiPro model. a Main components of the MiPro model: microbiome samples are cultured in an optimized cult...
Fig. 2
Fig. 2 PMC
Metaproteomics revealed taxonomic & functional composition stability over time. a Principal coordinate analysis (PCoA) plot with Bray-Curtis dis...
Fig. 3
Fig. 3 PMC
In vitro–in vivo correlation of taxonomic responses to metformin treatment. a Comparison of the change in relative abundance of the major gut bacter...
Fig. 4
Fig. 4 PMC
In vitro–in vivo correlation of microbiome pathway and enzyme responses to metformin. a Pathway analysis using the relative abundance of protein gro...